Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Study EV-103: Preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma Rosenberg, J. E., Flaig, T. W., Friedlander, T. W., Milowsky, M. I., Srinivas, S., Petrylak, D., Merchan, J. R., Bilen, M., Carret, A., Yuan, N., Sasse, C., Hoimes, C. J. AMER SOC CLINICAL ONCOLOGY. 2020
View details for Web of Science ID 000529525900470